Pharmaceutical care program in a service to people with disabilities

2012 ◽  
Vol 19 (2) ◽  
pp. 203.3-204
Author(s):  
C. Martínez Roca ◽  
A. Fernández Pérez ◽  
I. López Rodríguez ◽  
V.M. López García ◽  
P. Castellano Copa ◽  
...  
Keyword(s):  
Pharmaceutical Care ◽  
People With Disabilities ◽  
Care Program

Research for the Health Care Program and Health Promotion of People with Disabilities

2017 ◽  
Vol 7 (1) ◽  
pp. 153-157
Author(s):  
Mi Hee Cho ◽  
Dong Wook Shin ◽  
Jong Hyock Park ◽  
So Young Kim ◽  
Inuk Hwang ◽  
...  
Keyword(s):  
Health Care ◽  
Health Promotion ◽  
People With Disabilities ◽  
Care Program ◽  
Health Care Program

scholarly journals RESEARCH CAN CHANGE PROGRAMS AND POLICY

2019 ◽  
Vol 3 (Supplement_1) ◽  
pp. S232-S232
Author(s):  
Lori Gerhard
Keyword(s):  
Program Design ◽  
People With Disabilities ◽  
Care Program ◽  
The Other ◽  
Community Living ◽  
Us Guidance ◽  
Increasing Knowledge ◽  
Program Options ◽  
Source Of Information ◽  
Improve Practice

Abstract In addition to increasing knowledge, research is meant to improve practice and policy. The papers presented in this symposium draw from the experiences and insights of actual participants and their caregivers in major government-sponsored program options for people with disabilities wanting to remain in the community. Many of these programs are administered by our Administration for Community Living. For all, ACL serves as a main source of information for people in the community. These papers give us first-hand knowledge of what participants like and what they want improved. They give us guidance on how consumers define quality; the results can guide efforts to improve program design and the training of support brokers and representatives who assist people who want to manage their own supports and services. I will give a few examples starting with the paper on the Veterans-Directed Care Program and drawing ideas from the other papers.

scholarly journals Effect of a 36-month Pharmaceutical Care Program on the Coronary Heart Disease Risk in Elderly Diabetic and Hypertensive Patients

2011 ◽  
Vol 14 (2) ◽  
pp. 249 ◽  
Author(s):  
Paulo Roque Obreli Neto ◽  
Srecko Marusic ◽  
Divaldo Pereira De Lyra Júnior ◽  
Diogo Pilger ◽  
Joice Mara Cruciol-Souza ◽  
...  
Keyword(s):  
Coronary Heart Disease ◽  
Heart Disease ◽  
Pharmaceutical Care ◽  
Coronary Heart Disease Risk ◽  
Disease Risk ◽  
Intervention Group ◽  
Care Program ◽  
Control Group ◽  
Hypertensive Patients ◽  
Heart Disease Risk

Purpose. To examine the effect of a pharmaceutical care program on the coronary heart disease risk in elderly diabetic and hypertensive patients. Methods. A total of 200 elderly (> 60 years) diabetic and/or hypertensive patients were recruited into a randomized, controlled, prospective clinical trial with a 36-month follow-up, developed in a public primary health care unit in a municipality in the Brazilian State of Sao Paulo. A range of clinical measurements were evaluated at the baseline and up to 36 months afterwards. The intervention group patients received pharmaceutical care from a clinical pharmacist, whereas the control group patients received their usual care from the medical and nursing staff. The Framingham scoring method was used to estimate changes in the 10-year coronary heart disease risk scores of all the patients. Results. A total of 194 patients completed the study. Significant reductions (p < 0.05) in the mean values (baseline vs. 36 months) for the systolic blood pressure [156.7mmHg vs 133.7mmHg; p

Pharmaceutical care program for patients with reactive airways disease

2001 ◽  
Vol 58 (9) ◽  
pp. 791-796 ◽  
Author(s):  
Morris Weinberger ◽  
Michael D. Murray ◽  
David G. Marrero ◽  
Nancy Brewer ◽  
Michael Lykens ◽  
...  
Keyword(s):  
Pharmaceutical Care ◽  
Care Program ◽  
Reactive Airways
Sign in / Sign up

Export Citation Format

Share Document